Award-winning Creative Bolsters Team and Positions Agency as Creative AOR
MicroMass, a leading full-service health communications agency, and part of Ashfield Health, is proud to welcome Noah Lowenthal as Executive Creative Director. In this role, Lowenthal is responsible for defining and driving the creative vision and strategy for the agency. He will help evolve and elevate the agency’s creative services, drawing on over 20 years of experience leading in the creation of award-winning solutions and campaigns.
He previously served as Senior VP/Group Creative Director and shareholder at AbelsonTaylor, a Chicago-based health and wellness agency. In this role, he was the creative force behind multiple active brands, leading cross-functional creative teams in the delivery of integrated, breakthrough campaigns—all while spearheading various agency operational roles, including innovation, art production, and serving on the agency’s executive committee.
With a passion for connecting brand strategy to a differentiated creative platform, Lowenthal’s expertise will help build on the Human Dynamics approach of MicroMass, which aligns brands with the evolving needs of patients.
“MicroMass aims to understand the person to inspire the patient,” said President, Rosanne Johnson. “Noah’s innovative thinking and leadership will help us find unique ways to bring our creative solutions forward to amplify our human dynamics approach and make a positive impact for the brands and patients we serve.”
MicroMass launched Human Dynamics in June. This proprietary methodology is game-changer helping pharmaceutical brands connect with patients and create a better experience. “MicroMass is once again showcasing themselves as an industry leader,” said Ashfield Health Global President, Amar Urhekar. “I’m proud of the MicroMass team and their vision to bring in a talented creative leader and innovator with Noah. He will strengthen an already amazing team and connect patients with pharma brands in ways that make it matter.”
“There is so much talk across the industry about data and insights, but very little clear purpose or creative methodology on how to turn that information into creative that uniquely and reliably drives action,” said Noah Lowenthal. “The MicroMass behavioral science approach, when combined with an emphasis on experience design, is what allows us to not just see the human beneath the research, but to then move them, as a patient, to take action.”
Noah will serve on MicroMass’ executive team, alongside Roseanne Johnson (President), Phil Stein (CEO), Rob Peters (EVP, Strategy), and John Hamilton (EVP, Business Development). Lowenthal has garnered over 130 awards across digital, broadcast, and print mediums. This year he added a PM360 Elite Award and PharmaVOICE 100 to his trophy case.